UP!
|
Type
|
Public |
|---|---|
| Traded as | NYSE: EVHC S&P 500 Component |
| Industry | Healthcare |
| Headquarters | Nashville, Tennessee |
| Website | www |
Envision Healthcare is an American healthcare company and national hospital based physician group.
It has been a part of the S&P 500 index since December 2, 2016, where it replaced Legg Mason. It is part of GICS economic sector of Health Care and GICS Sub-Industry of Health Care Services. The company changed its name from AmSurg and its ticker from AMSG to EVHC.
Official website
| 2016-07-03 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-24 | Boost Price Target | Mizuho | Buy | $90.00 to $95.00 |
| 2016-06-17 | Reiterated Rating | Goldman Sachs | Buy | |
| 2016-06-17 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | |
| 2016-06-16 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2016-06-16 | Upgrade | Bank of America | Neutral to Buy | $104.00 |
| 2016-06-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-06-16 | Upgrade | Bank of America Corp. | Neutral to Buy | $104.00 |
| 2016-06-14 | Initiated Coverage | Wells Fargo | Market Perform | |
| 2016-06-14 | Initiated Coverage | Wells Fargo & Co. | Market Perform | |
| 2016-06-01 | Initiated Coverage | Barclays | Equal Weight | $85.00 |
| 2016-06-01 | Initiated Coverage | Barclays PLC | Equal Weight | $85.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-05-05 | Reiterated Rating | Jefferies Group | Buy | $96.00 |
| 2016-05-04 | Boost Price Target | Mizuho | Buy | $84.00 to $90.00 |
| 2016-03-31 | Initiated Coverage | Mizuho | Buy | $84.00 |
| 2016-02-25 | Reiterated Rating | Cantor Fitzgerald | Buy | $95.00 |
| 2016-02-19 | Reiterated Rating | Piper Jaffray | Buy | $90.00 to $86.00 |
| 2016-02-19 | Reiterated Rating | Piper Jaffray Cos. | Buy | $90.00 to $86.00 |
| 2016-01-06 | Initiated Coverage | Barclays | Equal Weight | $85.00 |
| 2015-12-15 | Reiterated Rating | Stephens | Buy | |
| 2015-12-14 | Boost Price Target | Stephens | Overweight | $91.00 to $97.00 |
| 2015-12-03 | Boost Price Target | KeyBanc | Overweight | $91.00 to $92.00 |
| 2015-12-03 | Boost Price Target | KeyCorp | Overweight | $91.00 to $92.00 |
| 2015-12-02 | Reiterated Rating | Stephens | Overweight | $91.00 |
| 2015-11-30 | Initiated Coverage | Goldman Sachs | Buy | $101.00 |
| 2015-11-05 | Reiterated Rating | Piper Jaffray | Buy | $82.00 to $90.00 |
| 2015-11-04 | Boost Price Target | KeyBanc | Overweight | $88.00 to $91.00 |
| 2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $94.00 |
| 2015-08-12 | Reiterated Rating | Cantor Fitzgerald | Buy | $95.00 |
| 2015-08-06 | Reiterated Rating | Cantor Fitzgerald | Buy | $95.00 |
| 2015-08-06 | Boost Price Target | Jefferies Group | Buy | $76.00 to $94.00 |
| 2015-08-05 | Reiterated Rating | Piper Jaffray | Buy | $72.00 to $82.00 |
| 2015-06-09 | Reiterated Rating | Jefferies Group | Buy | |
| 2015-06-05 | Initiated Coverage | Goldman Sachs | Buy | $81.00 |
| 2015-05-09 | Reiterated Rating | Jefferies Group | Buy | $68.00 to $76.00 |
| 2015-05-07 | Reiterated Rating | Cantor Fitzgerald | Buy | $67.00 to $75.00 |
| 2015-05-06 | Boost Price Target | Deutsche Bank | Buy | $74.00 to $77.00 |
| 2015-05-06 | Boost Price Target | Deutsche Bank AG | Buy | $74.00 to $77.00 |
| 2015-04-02 | Initiated Coverage | Stephens | Overweight | $77.00 |
| 2015-04-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $67.00 |
| 2015-03-02 | Boost Price Target | Citigroup Inc. | Buy | $58.00 to $67.00 |
| 2015-02-27 | Boost Price Target | Jefferies Group | Buy | $65.00 to $68.00 |
| 2015-02-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $65.00 |
| 2015-02-06 | Initiated Coverage | Jefferies Group | Buy | $65.00 |
| 2015-01-23 | Upgrade | Piper Jaffray | Neutral to Overweight | $54.00 to $65.00 |
| 2014-09-15 | Boost Price Target | Deutsche Bank | Buy | $56.00 to $65.00 |
| 2014-09-12 | Initiated Coverage | KeyBanc | Buy | $65.00 |
| 2014-09-03 | Initiated Coverage | Goldman Sachs | Neutral | $57.00 |
| 2014-08-04 | Boost Price Target | Piper Jaffray | $45.00 to $51.00 | |
| 2014-06-27 | Upgrade | Robert W. Baird | Neutral to Outperform | $44.00 to $55.00 |
| 2014-06-27 | Upgrade | SunTrust | Neutral to Buy | $50.00 to $54.00 |
| 2014-05-30 | Upgrade | Raymond James | Market Perform to Strong-Buy | $60.00 |
| 2014-05-29 | Upgrade | Deutsche Bank | Hold to Buy | $47.50 to $56.00 |
| 2014-04-24 | Lower Price Target | Barclays | Equal Weight | $50.00 to $49.00 |
| 2014-04-09 | Upgrade | Cantor Fitzgerald | Hold to Buy | $42.00 to $55.00 |
| 2013-12-09 | Initiated Coverage | Sidoti | Neutral | |
| 2013-11-25 | Initiated Coverage | Barclays | Equal Weight to Equal Weight | $52.00 |
| 2013-10-24 | Boost Price Target | Piper Jaffray | Neutral | $36.00 to $42.00 |
| 2013-10-23 | Boost Price Target | Deutsche Bank | Hold | $39.00 to $45.00 |
| 2013-07-26 | Reiterated | Cantor Fitzgerald | Hold | $31 to $37 |
| 2013-04-24 | Reiterated | Cantor Fitzgerald | Hold | $29 to $31 |
| 2011-04-08 | Reiterated | Barclays Capital | Equal Weight | $26 to $30 |
| 2011-03-10 | Reiterated | Barclays Capital | Equal Weight | $24 to $26 |
| 2011-01-18 | Reiterated | Deutsche Bank | Hold | $20 to $24 |
| 2010-09-13 | Reiterated | Barclays Capital | Equal Weight | $22 to $20 |
| 2010-07-23 | Reiterated | RBC Capital Mkts | Outperform | $24 to $22 |
| 2010-07-23 | Downgrade | Jefferies | Buy to Hold | $25 to $20 |
| 2010-07-20 | Initiated | Gleacher & Company | Neutral | $19 |
| 2010-05-18 | Initiated | Avondale | Mkt Perform | $32 |
| 2010-04-23 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2009-07-07 | Downgrade | Robert W. Baird | Outperform to Neutral | $24 to $23 |
| 2009-03-11 | Upgrade | Stifel Nicolaus | Hold to Buy | $22 |
| 2009-02-23 | Upgrade | Robert W. Baird | Neutral to Outperform | $24 |
| 2009-02-20 | Reiterated | Jefferies & Co | Buy | $31 to $24 |
| 2009-01-30 | Initiated | Robert W. Baird | Neutral | $27 |
| 2008-10-15 | Initiated | Sun Trust Rbsn Humphrey | Neutral |
| 2016-07-03 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-24 | Boost Price Target | Mizuho | Buy | $90.00 to $95.00 |
| 2016-06-17 | Reiterated Rating | Goldman Sachs | Buy | |
| 2016-06-17 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | |
| 2016-06-16 | Downgrade | Citigroup Inc. | Buy to Neutral |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AMSG 10 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 0.31M |
| MANAGED ACCOUNT ADVISORS LLC | 0.19M |
| ALYDAR PARTNERS LLC | 45000 |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 40245 |
| RUSSELL FRANK CO/ | 37768 |
| VTL Associates, LLC | 15095 |
| FIRSTMERIT BANK N A TRUSTEE | 5073 |
| Placemark Investments, Inc. | 4398 |
| FolioMetrix LLC | 3286 |
| BOSTON PRIVATE BANK & TRUST CO | 19 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| HOLDEN CHRISTOPHER A President and CEO | 1.12% (539281) | AMSG / |
| CIGARRAN THOMAS G | 0.33% (157760) | AMSG / HWAY / |
| GULMI CLAIRE M Executive VP & CFO | 0.24% (115333) | AIRM / AMSG / |
| Coward Robert Jon Executive Vice President | 0.23% (112507) | AMSG / |
| HERR HENRY D | 0.23% (109666) | AMSG / |
| MANNING DAVID L EVP-Chief Development Officer | 0.18% (85650) | AMSG / |
| Clendenin Phillip A SVP Corporate Services | 0.10% (47324) | AMSG / |
| Eastridge Kevin Delon Sr. VP of Finance, CAO | 0.10% (45888) | AMSG / |
| DEAL JAMES A | 0.07% (33658) | AMSG / |
| GERINGER STEVEN I | 0.05% (23864) | ADUS / AMSG / |
| Payne Billie Aileen Senior VP of Operations | 0.04% (18721) | AMSG / |
| Miller Cynthia S | 0.03% (16251) | AMSG / |
| Lavender Kevin P | 0.03% (12180) | AMSG / |
| Strash Shawn Gunther SVP Corporate Services | 0.03% (12113) | AMSG / |
| Kelly Christopher Roberts SVP and General Counsel | 0.02% (11843) | AMSG / |
| JACOBS JOEY A | 0.02% (10331) | ACHC / AMSG / CPIX / |
| Popp John William Jr. | 0.01% (6862) | AMSG / |
| Gawaluck John Thomas | 0.01% (4580) | AMSG / |
UM